Direct infection of the endothelium by SARS-CoV-2 potentially damages endothelial surface, suppressing the expression of TFPI, TM, and EPCR, which is thought to the leading cause of procoagulant state in COVID-19 patients (31). This evidence concerns the gene THBD and COVID-19.